Using Magnetocardiography to Detect Myocardial Ischemia Compared to SPECT in Adults with Chest Pain and Coronary Stenosis

What this Trial Is About

Researchers are evaluating the ability of Magnetocardiography MCG to detect myocardial ischemia in patients suspected of having non-ST-elevation acute coronary syndrome NSTE-ACS. The study uses Single Photon Emission Computed Tomography SPECT as the gold standard to determine the presence and severity of myocardial ischemia, aiming to compare MCGs effectiveness against this established imaging technique. Participants will undergo MCG and SPECT examinations to assess myocardial ischemia. SPECT serves as a reference standard to evaluate the accuracy of MCG in detecting ischemia. The study also examines MCGs performance in patients with coronary stenosis less than 50%, focusing on ischemia without obstructive coronary artery disease INOCA. The observation period lasts from enrollment until discharge, up to 30 days. During the study, patients with symptoms of myocardial ischemia will be monitored and assessed through the two imaging methods. Researchers will measure the efficacy of MCG in identifying ischemia compared to SPECT results. Safety and eligibility are carefully evaluated, excluding certain conditions such as recent myocardial infarction or severe renal impairment. The studys total participation duration will be up to 30 days, including enrollment and discharge evaluations.

Diagnosis of Myocardial Ischemia With MCG Using SPECT as a Reference Standard